DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

Mylan Inc. (NASDAQ: MYL)

53.55 1.18 (2.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYL $53.55 2.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.44
Previous Close $52.37
Daily Range $53.15 - $56.10
52-Week Range $36.97 - $57.52
Market Cap $20.0B
P/E Ratio 22.67
Dividend (Yield) $0.00 (0.0%)
Volume 9,033,152
Average Daily Volume 5,128,411
Current FY EPS $3.48

Sector

Healthcare

Industry

Drugs

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary Rss Feed

Is Mylan's Lively Third Quarter the Start of Something Special?

Mylan posts Street-beating top and bottom lines behind strong growth in Q3 -- and successfully completing its agreement to purchase a portion of Abbott Labs' generics business could lead to more success ahead.

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Mylan Beats, Raises Earnings Guidance; Abbott Deal on Track - Analyst Blog

Mylan (MYL) Earnings Report: Q3 2014 Conference Call Transcript

Mylan (MYL) Highlighted As Momo Momentum Stock

Pfizer's Trumenba Gains Accelerated Approval in the U.S. - Analyst Blog

Mylan's (MYL) CEO Heather Bresch on Q3 2014 Results - Earnings Call Transcript

Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y - Analyst Blog

Mylan (MYL) Stock Higher In After-Hours Trading Following Third Quarter Earnings Results

Mylan (MYL) Q3 2014 Results - Earnings Call Webcast

See More MYL News...

MYL's Top Competitors

MYL $53.55 (2.25%)
Current stock: MYL
NVS $92.69 (0.80%)
Current stock: NVS
PFE $29.95 (0.37%)
Current stock: PFE
JNJ $107.78 (0.69%)
Current stock: JNJ